Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 66

1.

Clonal immunoglobulin λ light-chain gene rearrangements detected by next generation sequencing in POEMS syndrome.

Kawajiri-Manako C, Mimura N, Fukuyo M, Namba H, Rahmutulla B, Nagao Y, Togasaki E, Shimizu R, Oshima-Hasegawa N, Tsukamoto S, Mitsukawa S, Takeda Y, Ohwada C, Takeuchi M, Iseki T, Misawa S, Yokote K, Tsuiji M, Kuwabara S, Sakaida E, Kaneda A, Nakaseko C.

Am J Hematol. 2018 Jul 17. doi: 10.1002/ajh.25213. [Epub ahead of print]

PMID:
30015379
2.

Long-term complete remission following tandem autologous stem cell transplantation and consolidative radiotherapy for refractory mediastinal gray-zone lymphoma.

Takaishi K, Muto T, Mimura N, Takiguchi J, Nagao Y, Oshima-Hasegawa N, Tsukamoto S, Takeda Y, Mitsukawa S, Takeuchi M, Ohwada C, Ota S, Iseki T, Nakaseko C, Sakaida E.

Int J Hematol. 2018 May 21. doi: 10.1007/s12185-018-2471-x. [Epub ahead of print]

PMID:
29786758
3.

Long-term evaluation of physical improvement and survival of autologous stem cell transplantation in POEMS syndrome.

Ohwada C, Sakaida E, Kawajiri-Manako C, Nagao Y, Oshima-Hasegawa N, Togasaki E, Muto T, Tsukamoto S, Mitsukawa S, Takeda Y, Mimura N, Takeuchi M, Shimizu N, Misawa S, Iseki T, Kuwabara S, Nakaseko C.

Blood. 2018 May 10;131(19):2173-2176. doi: 10.1182/blood-2017-07-795385. Epub 2018 Mar 29. No abstract available.

PMID:
29599110
4.

Efficacy and Long-Term Outcomes of Autologous Stem Cell Transplantation in POEMS Syndrome: A Nationwide Survey in Japan.

Kawajiri-Manako C, Sakaida E, Ohwada C, Miyamoto T, Azuma T, Taguchi J, Mori T, Hasegawa Y, Kondo T, Yujiri T, Yoshimitsu M, Imada K, Kurahashi S, Kahata K, Ichinohe T, Hirokawa M, Atsuta Y, Nakaseko C.

Biol Blood Marrow Transplant. 2018 Jun;24(6):1180-1186. doi: 10.1016/j.bbmt.2018.01.026. Epub 2018 Feb 1.

PMID:
29409882
5.

Prognostic analysis according to the 2017 ELN risk stratification by genetics in adult acute myeloid leukemia patients treated in the Japan Adult Leukemia Study Group (JALSG) AML201 study.

Harada Y, Nagata Y, Kihara R, Ishikawa Y, Asou N, Ohtake S, Miyawaki S, Sakura T, Ozawa Y, Usui N, Kanamori H, Ito Y, Imai K, Suehiro Y, Kobayashi S, Kitamura K, Sakaida E, Onizuka M, Takeshita A, Ishida F, Suzushima H, Ishizawa K, Naoe T, Matsumura I, Miyazaki Y, Ogawa S, Kiyoi H; Japan Adult Leukemia Study Group JALSG.

Leuk Res. 2018 Mar;66:20-27. doi: 10.1016/j.leukres.2018.01.008. Epub 2018 Jan 17.

PMID:
29360622
6.

Long-term efficacy of partial splenic embolization for the treatment of steroid-resistant chronic immune thrombocytopenia.

Togasaki E, Shimizu N, Nagao Y, Kawajiri-Manako C, Shimizu R, Oshima-Hasegawa N, Muto T, Tsukamoto S, Mitsukawa S, Takeda Y, Mimura N, Ohwada C, Takeuchi M, Sakaida E, Iseki T, Yoshitomi H, Ohtsuka M, Miyazaki M, Nakaseko C.

Ann Hematol. 2018 Apr;97(4):655-662. doi: 10.1007/s00277-018-3232-x. Epub 2018 Jan 13.

PMID:
29332223
7.

Successful Treatment of Rapidly Progressive Life-Threatening Esophageal Submucosal Hematoma in a Patient With van der Hoeve Syndrome.

Watanabe Y, Shimizu N, Iwakawa M, Yamaguchi T, Ban N, Kawana H, Saiki A, Sakaida E, Nakaseko C, Matsuura Y, Aotsuka N, Bujo H, Tatsuno I.

J Clin Med Res. 2018 Feb;10(2):154-157. doi: 10.14740/jocmr3270w. Epub 2017 Dec 30.

8.

Prognostic value of genetic mutations in adolescent and young adults with acute myeloid leukemia.

Kuwatsuka Y, Tomizawa D, Kihara R, Nagata Y, Shiba N, Iijima-Yamashita Y, Shimada A, Deguchi T, Miyachi H, Tawa A, Taga T, Kinoshita A, Nakayama H, Kiyokawa N, Saito AM, Koh K, Goto H, Kosaka Y, Asou N, Ohtake S, Miyawaki S, Miyazaki Y, Sakura T, Ozawa Y, Usui N, Kanamori H, Ito Y, Imai K, Suehiro Y, Kobayashi S, Kitamura K, Sakaida E, Ogawa S, Naoe T, Hayashi Y, Horibe K, Manabe A, Mizutani S, Adachi S, Kiyoi H.

Int J Hematol. 2018 Feb;107(2):201-210. doi: 10.1007/s12185-017-2340-z. Epub 2017 Oct 12.

PMID:
29027108
9.

Syndrome of Inappropriate Antidiuretic Hormone Secretion in a Patient with Mucosa-associated Lymphoid Tissue Lymphoma.

Shimizu N, Tanaka S, Watanabe Y, Tokuyama W, Hiruta N, Ohwada C, Sakaida E, Nakaseko C, Tatsuno I.

Intern Med. 2017 Dec 1;56(23):3225-3229. doi: 10.2169/internalmedicine.9048-17. Epub 2017 Oct 11.

10.

CD20 positivity and white blood cell count predict treatment outcomes in Philadelphia chromosome-negative acute lymphoblastic leukemia patients ineligible for pediatric-inspired chemotherapy.

Isshiki Y, Ohwada C, Sakaida E, Onoda M, Aotsuka N, Tanaka H, Fukazawa M, Cho R, Sugawara T, Kawaguchi T, Hara S, Yokota A.

Jpn J Clin Oncol. 2017 Nov 1;47(11):1047-1054. doi: 10.1093/jjco/hyx126.

PMID:
28973362
11.

Frequent somatic mutations in epigenetic regulators in newly diagnosed chronic myeloid leukemia.

Togasaki E, Takeda J, Yoshida K, Shiozawa Y, Takeuchi M, Oshima M, Saraya A, Iwama A, Yokote K, Sakaida E, Hirase C, Takeshita A, Imai K, Okumura H, Morishita Y, Usui N, Takahashi N, Fujisawa S, Shiraishi Y, Chiba K, Tanaka H, Kiyoi H, Ohnishi K, Ohtake S, Asou N, Kobayashi Y, Miyazaki Y, Miyano S, Ogawa S, Matsumura I, Nakaseko C, Naoe T.

Blood Cancer J. 2017 Apr 28;7(4):e559. doi: 10.1038/bcj.2017.36.

12.

Potential Activity of Amrubicin as a Salvage Therapy for Merkel Cell Carcinoma.

Sakaida E, Ebata T, Iwasawa S, Kurimoto R, Yonemori S, Ota S, Nakatani Y, Sekine I, Takiguchi Y.

Intern Med. 2017;56(5):567-570. doi: 10.2169/internalmedicine.56.7675. Epub 2017 Mar 1.

13.

The Successful Treatment of a Cord Blood Transplant Recipient with Varicella Zoster Virus Meningitis, Radiculitis and Myelitis with Foscarnet.

Shimizu R, Ohwada C, Nagao Y, Togasaki E, Kawajiri C, Muto T, Tsukamoto S, Sakai S, Takeda Y, Mimura N, Takeuchi M, Sakaida E, Iseki T, Nakaseko C.

Intern Med. 2017;56(3):353-356. doi: 10.2169/internalmedicine.56.6930. Epub 2017 Feb 1.

14.

Safety and Efficacy of Granulocyte Colony-Stimulating Factor Monotherapy for Peripheral Blood Stem Cell Collection in POEMS Syndrome.

Muto T, Ohwada C, Takaishi K, Isshiki Y, Nagao Y, Hasegawa N, Kawajiri-Manako C, Togasaki E, Shimizu R, Tsukamoto S, Sakai S, Takeda Y, Mimura N, Takeuchi M, Sakaida E, Misawa S, Shimizu N, Iseki T, Kuwabara S, Nakaseko C.

Biol Blood Marrow Transplant. 2017 Feb;23(2):361-363. doi: 10.1016/j.bbmt.2016.10.024. Epub 2016 Nov 10.

15.

Prognostic impact of serum soluble LR11 in newly diagnosed diffuse large B-cell lymphoma: A multicenter prospective analysis.

Sugita Y, Ohwada C, Kawaguchi T, Muto T, Tsukamoto S, Takeda Y, Mimura N, Takeuchi M, Sakaida E, Shimizu N, Tanaka H, Abe D, Fukazawa M, Sugawara T, Aotsuka N, Nishiwaki K, Shono K, Ebinuma H, Fujimura K, Bujo H, Yokote K, Nakaseko C.

Clin Chim Acta. 2016 Dec 1;463:47-52. doi: 10.1016/j.cca.2016.10.008. Epub 2016 Oct 8.

PMID:
27725222
16.

Possible role of intragenic DNA hypermethylation in gene silencing of the tumor suppressor gene NR4A3 in acute myeloid leukemia.

Shimizu R, Muto T, Aoyama K, Choi K, Takeuchi M, Koide S, Hasegawa N, Isshiki Y, Togasaki E, Kawajiri-Manako C, Nagao Y, Tsukamoto S, Sakai S, Takeda Y, Mimura N, Ohwada C, Sakaida E, Iseki T, Starczynowski DT, Iwama A, Yokote K, Nakaseko C.

Leuk Res. 2016 Nov;50:85-94. doi: 10.1016/j.leukres.2016.09.018. Epub 2016 Sep 26.

17.

Severe stomatitis and ileocecal perforation developed after all-trans retinoic acid monotherapy in an HLA-B51-positive patient with acute promyelocytic leukemia.

Kimura K, Takeuchi M, Hasegawa N, Togasaki E, Shimizu R, Kawajiri C, Muto T, Tsukamoto S, Takeda Y, Ohwada C, Sakaida E, Sakai S, Mimura N, Ota S, Iseki T, Nakaseko C.

Rinsho Ketsueki. 2016 Jun;57(6):765-70. doi: 10.11406/rinketsu.57.765. Review. Japanese.

PMID:
27384858
18.

Chronic active Epstein-Barr virus infection with marked pericardial effusion successfully treated with allogeneic peripheral blood stem cell transplantation.

Matsui S, Takeda Y, Isshiki Y, Yamazaki A, Nakao S, Takaishi K, Nagao Y, Hasegawa N, Togasaki E, Shimizu R, Kawajiri C, Sakai S, Mimura N, Takeuchi M, Ohwada C, Sakaida E, Iseki T, Imadome K, Nakaseko C.

Rinsho Ketsueki. 2016 May;57(5):624-9. doi: 10.11406/rinketsu.57.624. Review. Japanese.

PMID:
27263789
19.

Feasibility study of first-line chemotherapy using Pemetrexed and Bevacizumab for advanced or recurrent nonsquamous non-small cell lung cancer in elderly patients: TORG1015.

Kozuki T, Nogami N, Kitajima H, Iwasawa S, Sakaida E, Takiguchi Y, Ikeda S, Yoshida M, Kato T, Miyamoto S, Sakamaki K, Shinkai T, Watanabe K.

BMC Cancer. 2016 May 12;16:306. doi: 10.1186/s12885-016-2338-6.

20.

Early-Onset Severe Diffuse Alveolar Hemorrhage after Bortezomib Administration Suggestive of Pulmonary Involvement of Myeloma Cells.

Sugita Y, Ohwada C, Nagao Y, Kawajiri C, Shimizu R, Togasaki E, Yamazaki A, Muto T, Sakai S, Takeda Y, Mimura N, Takeuchi M, Sakaida E, Iseki T, Yokote K, Nakaseko C.

J Clin Exp Hematop. 2015;55(3):163-8. doi: 10.3960/jslrt.55.163. Review.

21.

Safety of a short hydration method for cisplatin administration in comparison with a conventional method-a retrospective study.

Sakaida E, Iwasawa S, Kurimoto R, Ebata T, Imai C, Oku T, Sekine I, Tada Y, Tatsumi K, Takiguchi Y.

Jpn J Clin Oncol. 2016 Apr;46(4):370-7. doi: 10.1093/jjco/hyv203. Epub 2016 Jan 10.

22.

Successful Allogeneic Stem Cell Transplantation for Severe Aplastic Anemia after Treatment of Lymphoproliferative Disorder Caused by Rabbit Antithymocyte Globulin.

Tsukamoto S, Nagao Y, Yamazaki A, Sugita Y, Muto T, Sakai S, Takeda Y, Mimura N, Takeuchi M, Ohwada C, Sakaida E, Yokote K, Iseki T, Nakaseko C.

Intern Med. 2015;54(24):3197-200. doi: 10.2169/internalmedicine.54.5090. Epub 2015 Dec 15.

23.

Successful treatment of cytomegalovirus enteritis after unrelated allogeneic stem cell transplantation by the infusion of ex vivo-expanded CD4+ lymphocytes derived from the recipient's peripheral blood donor cells.

Muto T, Takeda Y, Tsukamoto S, Sakai S, Mimura N, Ohwada C, Takeuchi M, Sakaida E, Ota S, Iseki T, Shimizu N, Morio T, Nakaseko C.

Transpl Infect Dis. 2016 Feb;18(1):93-7. doi: 10.1111/tid.12487. Epub 2016 Jan 30.

PMID:
26613364
24.

Acutely deteriorated extravascular volume overload during peripheral blood stem cell mobilization in POEMS syndrome: A case series with cytokine analysis.

Muto T, Ohwada C, Sawai S, Beppu M, Tsukamoto S, Takeda Y, Mimura N, Takeuchi M, Sakaida E, Sogawa K, Misawa S, Shimizu N, Iseki T, Nomura F, Kuwabara S, Nakaseko C.

Transfus Apher Sci. 2016 Apr;54(2):276-81. doi: 10.1016/j.transci.2015.10.016. Epub 2015 Nov 4.

PMID:
26586169
25.

Vascular endothelial growth factor as a predictive marker for POEMS syndrome treatment response: retrospective cohort study.

Misawa S, Sato Y, Katayama K, Hanaoka H, Sawai S, Beppu M, Nomura F, Shibuya K, Sekiguchi Y, Iwai Y, Watanabe K, Amino H, Ohwada C, Takeuchi M, Sakaida E, Nakaseko C, Kuwabara S.

BMJ Open. 2015 Nov 11;5(11):e009157. doi: 10.1136/bmjopen-2015-009157.

26.

Gradually-Deteriorating Liver Function due to Iron Overload Over Four Years after Allogeneic Stem Cell Transplantation.

Tanaka H, Kawajiri C, Sakai S, Takeda Y, Kawaguchi T, Mimura N, Sakaida E, Ohwada C, Takeuchi M, Hashimoto S, Takagi T, Nakaseko C.

J Clin Exp Hematop. 2015;55(2):109-12. doi: 10.3960/jslrt.55.109.

27.

Effect of the order of TBI and cyclophosphamide administration on the outcome of allogeneic hematopoietic stem cell transplantation.

Motohashi K, Fujisawa S, Onizuka M, Kako S, Sakaida E, Shono K, Tatara R, Doki N, Mori T, Sakura T, Aotsuka N, Fuji E, Tomita N, Kawai N, Saitoh T, Usuki K, Taguchi J, Watanabe R, Kobayashi S, Yano S, Kanamori H, Takahashi S, Okamoto S.

Bone Marrow Transplant. 2015 Nov;50(11):1476-9. doi: 10.1038/bmt.2015.142. Epub 2015 Jul 20. No abstract available.

PMID:
26191948
28.

Long-term complete remission by infusion of ex vivo-expanded donor-derived CD4(+) lymphocytes for treating an early relapse of Hodgkin lymphoma after cord blood transplantation.

Muto T, Ohwada C, Yamazaki A, Sugita Y, Tsukamoto S, Sakai S, Takeda Y, Mimura N, Takeuchi M, Sakaida E, Iseki T, Shimizu N, Morio T, Nakaseko C.

Leuk Lymphoma. 2016;57(1):230-2. doi: 10.3109/10428194.2015.1041390. Epub 2015 Jun 18. No abstract available.

PMID:
25962436
29.

Alveolar hemorrhage associated with pemetrexed administration.

Kurimoto R, Sekine I, Iwasawa S, Sakaida E, Tada Y, Tatsumi K, Takahashi Y, Nakatani Y, Imai C, Takiguchi Y.

Intern Med. 2015;54(7):833-6. doi: 10.2169/internalmedicine.54.3414. Epub 2015 Apr 1.

30.

Efficacy of myeloablative allogeneic hematopoietic stem cell transplantation in adult patients with MLL-ELL-positive acute myeloid leukemia.

Muto T, Takeuchi M, Yamazaki A, Sugita Y, Tsukamoto S, Sakai S, Takeda Y, Mimura N, Ohwada C, Sakaida E, Aotsuka N, Iseki T, Nakaseko C.

Int J Hematol. 2015 Jul;102(1):86-92. doi: 10.1007/s12185-015-1779-z. Epub 2015 Mar 11.

PMID:
25758097
31.

Serum soluble LR11, a novel tumor derived biomarker associated with the outcome of patients with diffuse large B-cell lymphoma.

Ohwada C, Yamazaki A, Kawaguchi T, Sugita Y, Takeuchi M, Shimizu N, Sakaida E, Takeda Y, Tsukamoto S, Muto T, Jiang M, Higashi M, Yokote K, Tamaru J, Bujo H, Nakaseko C.

Leuk Lymphoma. 2015;56(10):2982-5. doi: 10.3109/10428194.2015.1016930. Epub 2015 Mar 11. No abstract available.

PMID:
25676033
32.

[Treatment of multiple myeloma with lenalidomide and bortezomib combination therapy].

Takeda Y, Sakaida E, Nakaseko C.

Nihon Rinsho. 2015 Jan;73(1):130-6. Japanese.

PMID:
25626318
33.

Reactivation of hepatitis B virus in hematopoietic stem cell transplant recipients in Japan: efficacy of nucleos(t)ide analogues for prevention and treatment.

Nakamoto S, Kanda T, Nakaseko C, Sakaida E, Ohwada C, Takeuchi M, Takeda Y, Mimura N, Iseki T, Wu S, Arai M, Imazeki F, Saito K, Shirasawa H, Yokosuka O.

Int J Mol Sci. 2014 Nov 21;15(11):21455-67. doi: 10.3390/ijms151121455.

34.

Acute myeloid leukemia concurrent with spinal epidural extramedullary myeloid sarcoma accompanied by a high CD25 expression and the FLT3-ITD mutation.

Isshiki Y, Ohwada C, Togasaki E, Shimizu R, Hasegawa N, Yamazaki A, Sugita Y, Kawaguchi T, Tsukamoto S, Sakai S, Takeda Y, Takeuchi M, Sakaida E, Shimizu N, Ota S, Yokote K, Iseki T, Nakaseko C.

Intern Med. 2014;53(11):1159-64. Epub 2014 Jun 1.

35.

Current status of medical oncology in Japan--reality gleaned from a questionnaire sent to designated cancer care hospitals.

Takiguchi Y, Sekine I, Iwasawa S, Kurimoto R, Sakaida E, Tamura K.

Jpn J Clin Oncol. 2014 Jul;44(7):632-40. doi: 10.1093/jjco/hyu059. Epub 2014 May 12.

PMID:
24821975
36.

Tetraspanin CD9 modulates ADAM17-mediated shedding of LR11 in leukocytes.

Tsukamoto S, Takeuchi M, Kawaguchi T, Togasaki E, Yamazaki A, Sugita Y, Muto T, Sakai S, Takeda Y, Ohwada C, Sakaida E, Shimizu N, Nishii K, Jiang M, Yokote K, Bujo H, Nakaseko C.

Exp Mol Med. 2014 Apr 4;46:e89. doi: 10.1038/emm.2013.161.

37.

Successful treatment of Philadelphia chromosome-positive mixed phenotype acute leukemia by appropriate alternation of second-generation tyrosine kinase inhibitors according to BCR-ABL1 mutation status.

Kawajiri C, Tanaka H, Hashimoto S, Takeda Y, Sakai S, Takagi T, Takeuchi M, Ohwada C, Sakaida E, Shimizu N, Nakaseko C.

Int J Hematol. 2014 Apr;99(4):513-8. doi: 10.1007/s12185-014-1531-0. Epub 2014 Feb 15.

PMID:
24532437
38.

Potential utility of serum soluble LR11 as a diagnostic biomarker for intravascular large B-cell lymphoma.

Kawaguchi T, Ohwada C, Takeuchi M, Shimizu N, Sakaida E, Takeda Y, Sakai S, Tsukamoto S, Yamazaki A, Sugita Y, Higashi M, Fujikawa K, Matsue K, Yokote K, Tamaru J, Bujo H, Nakaseko C.

Leuk Lymphoma. 2014 Oct;55(10):2391-4. doi: 10.3109/10428194.2014.880430. Epub 2014 Mar 7. No abstract available.

PMID:
24401112
39.

Circulating LR11 is a novel soluble-receptor marker for early-stage clinical conditions in patients with non-Hodgkin's lymphoma.

Fujimura K, Ebinuma H, Fukamachi I, Ohwada C, Kawaguchi T, Shimizu N, Takeuchi M, Sakaida E, Jiang M, Nakaseko C, Bujo H.

Clin Chim Acta. 2014 Mar 20;430:48-54. doi: 10.1016/j.cca.2013.12.039. Epub 2014 Jan 4.

PMID:
24394293
40.

Extramedullary blast crisis of chronic myelogenous leukemia as an initial presentation.

Tsukamoto S, Ota S, Ohwada C, Takeda Y, Takeuchi M, Sakaida E, Shimizu N, Yokote K, Iseki T, Nakaseko C.

Leuk Res Rep. 2013 Aug 13;2(2):67-9. doi: 10.1016/j.lrr.2013.07.002. eCollection 2013.

41.

Secondary neurolymphomatosis detected by whole-body diffusion-weighted magnetic resonance imaging: a case report.

Tanaka H, Yoshino K, Sakaida E, Hashimoto S, Takeda Y, Kawajiri C, Takagi T, Nakaseko C.

J Clin Exp Hematop. 2013;53(3):221-6.

42.

Incidence, risk factors and treatment outcomes of extravasation of cytotoxic agents in an outpatient chemotherapy clinic.

Sakaida E, Sekine I, Iwasawa S, Kurimoto R, Uehara T, Ooka Y, Akanuma N, Tada Y, Imai C, Oku T, Takiguchi Y.

Jpn J Clin Oncol. 2014 Feb;44(2):168-71. doi: 10.1093/jjco/hyt186. Epub 2013 Dec 2.

PMID:
24302758
43.

Choroidal metastasis of non-small cell lung cancer that responded to gefitinib.

Shimomura I, Tada Y, Miura G, Suzuki T, Matsumura T, Tsushima K, Terada J, Kurimoto R, Sakaida E, Sekine I, Takiguchi Y, Yamamoto S, Tatsumi K.

Case Rep Ophthalmol Med. 2013;2013:213124. doi: 10.1155/2013/213124. Epub 2013 Sep 12.

44.

Effect of metformin on residual cells after chemotherapy in a human lung adenocarcinoma cell line.

Kitazono S, Takiguchi Y, Ashinuma H, Saito-Kitazono M, Kitamura A, Chiba T, Sakaida E, Sekine I, Tada Y, Kurosu K, Sakao S, Tanabe N, Iwama A, Yokosuka O, Tatsumi K.

Int J Oncol. 2013 Dec;43(6):1846-54. doi: 10.3892/ijo.2013.2120. Epub 2013 Oct 3.

45.

LR11: a novel biomarker identified in follicular lymphoma.

Kawaguchi T, Ohwada C, Takeuchi M, Shimizu N, Sakaida E, Takeda Y, Sakai S, Tsukamoto S, Yamazaki A, Sugita Y, Jiang M, Higashi M, Yokote K, Tamaru J, Bujo H, Nakaseko C.

Br J Haematol. 2013 Oct;163(2):277-80. doi: 10.1111/bjh.12467. Epub 2013 Jul 13. No abstract available.

PMID:
23848957
46.

Successful treatment by azacitidine therapy of intestinal Behçet's disease associated with myelodysplastic syndrome.

Tanaka H, Shimizu N, Tougasaki E, Kawajiri C, Hashimoto S, Takeda Y, Sakai S, Takeuchi M, Ohwada C, Sakaida E, Takagi T, Nakaseko C.

Int J Hematol. 2013 Apr;97(4):520-4. doi: 10.1007/s12185-013-1316-x. Epub 2013 Mar 22.

PMID:
23519573
47.

Severe hyponatremia caused by syndrome of inappropriate secretion of antidiuretic hormone developed as initial manifestation of human herpesvirus-6-associated acute limbic encephalitis after unrelated bone marrow transplantation.

Kawaguchi T, Takeuchi M, Kawajiri C, Abe D, Nagao Y, Yamazaki A, Sugita Y, Tsukamoto S, Sakai S, Takeda Y, Ohwada C, Sakaida E, Shimizu N, Yokote K, Iseki T, Nakaseko C.

Transpl Infect Dis. 2013 Apr;15(2):E54-7. doi: 10.1111/tid.12029. Epub 2012 Nov 23.

PMID:
23173742
48.

Mobilization of PBSCs in poor mobilizers with POEMS syndrome using G-CSF with plerixafor.

Shimizu N, Sakaida E, Ohwada C, Takeuchi M, Kawaguchi T, Tsukamoto S, Sakai S, Takeda Y, Sugita Y, Yokote K, Iseki T, Isose S, Kanai K, Misawa S, Kuwabara S, Nakaseko C.

Bone Marrow Transplant. 2012 Dec;47(12):1587-8. doi: 10.1038/bmt.2012.80. Epub 2012 May 21. No abstract available.

PMID:
22609884
49.

Antiproliferative action of metformin in human lung cancer cell lines.

Ashinuma H, Takiguchi Y, Kitazono S, Kitazono-Saitoh M, Kitamura A, Chiba T, Tada Y, Kurosu K, Sakaida E, Sekine I, Tanabe N, Iwama A, Yokosuka O, Tatsumi K.

Oncol Rep. 2012 Jul;28(1):8-14. doi: 10.3892/or.2012.1763. Epub 2012 Apr 18.

PMID:
22576795
50.

Interaction and cross-resistance of cisplatin and pemetrexed in malignant pleural mesothelioma cell lines.

Kitazono-Saitoh M, Takiguchi Y, Kitazono S, Ashinuma H, Kitamura A, Tada Y, Kurosu K, Sakaida E, Sekine I, Tanabe N, Tagawa M, Tatsumi K.

Oncol Rep. 2012 Jul;28(1):33-40. doi: 10.3892/or.2012.1799. Epub 2012 May 4.

PMID:
22562354

Supplemental Content

Loading ...
Support Center